Arcus Biosciences Inc. (RCUS) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Arcus Biosciences Inc.

    NYSE: RCUS · Real-Time Price · USD
    11.50
    -0.22 (-1.88%)
    At close: Sep 11, 2025, 3:59 PM
    11.39
    -0.92%
    After-hours: Sep 11, 2025, 05:16 PM EDT

    Arcus Biosciences Income Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Revenue
    		 258M 117M 112M 383M
    Cost of Revenue
    		 n/a n/a n/a n/a
    Gross Profit
    		 258M 117M 112M 383M
    Operating Income
    		 -330M -340M -280M 54M
    Interest Income
    		 52M 41M 16M 1M
    Pretax Income
    		 -283M -301M -266M 55M
    Net Income
    		 -283M -307M -267M 53M
    Selling & General & Admin
    		 120M 117M 104M 72M
    Research & Development
    		 448M 340M 288M 257M
    Other Expenses
    		 20M n/a n/a n/a
    Operating Expenses
    		 588M 457M 392M 329M
    Interest Expense
    		 4M 2M 2M n/a
    Selling & Marketing Expenses
    		 n/a n/a n/a n/a
    Cost & Expenses
    		 588M 457M 392M 329M
    Income Tax Expense
    		 1M 6M 1M 2M
    Shares Outstanding (Basic)
    		 90.1M 74M 72M 69.35M
    Shares Outstanding (Diluted)
    		 90.1M 74M 72M 73.97M
    EPS (Basic)
    		 -3.14 -4.15 -3.71 0.76
    EPS (Diluted)
    		 -3.14 -4.15 -3.71 0.71
    EBITDA
    		 -269M -291M -258M 59M
    EBIT
    		 -279M -299M -264M 55M
    Depreciation & Amortization
    		 10M 8M 6M 4M

    Add to Watchlist